$350 | Single User
$700 | Site License
$1050 | Enterprise License

Global Biotechnology
[Lowest Price Guaranteed: $350]

Published by Marketline: 17 Dec 2019 | 260953 | In Stock
Related Topics: Biotechnology

Introduction

Global Biotechnology

Summary

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

- The global biotechnology industry had total revenues of 0.0bn in 2018, representing a compound annual growth rate (CAGR) of 8.5% between 2014 and 2018.

- The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of 1.6bn, equivalent to 58.4% of the industry's overall value.

- The US industry is by far the largest industry globally, accounting for 48.2% of its total value in 2018; as a result its performance weighs heavily on the global industry. Other prominent industries include Japan, China, and Germany, which are all experiencing varying rates of growth.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the Global biotechnology market by value in 2018?

- What will be the size of the Global biotechnology market in 2023?

- What factors are affecting the strength of competition in the Global biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the global's biotechnology market?

Table of Contents
for Global Biotechnology

  • Table of Contents

    1 Executive Summary

    1.1. Market value

    1.2. Market value forecast

    1.3. Category segmentation

    1.4. Geography segmentation

    1.5. Market rivalry

    1.6. Competitive Landscape

    2 Market Overview

    2.1. Market definition

    2.2. Market analysis

    3 Market Data

    3.1. Market value

    4 Market Segmentation

    4.1. Category segmentation

    4.2. Geography segmentation

    5 Market Outlook

    5.1. Market value forecast

    6 Five Forces Analysis

    6.1. Summary

    6.2. Buyer power

    6.3. Supplier power

    6.4. New entrants

    6.5. Threat of substitutes

    6.6. Degree of rivalry

    7 Competitive Landscape

    7.1. Who are the leading players in the market?

    7.2. What strategies do leading players follow?

    7.3. Have there been any product approvals in recent years?

    7.4. What has been the rationale behind recent M&A activity?

    7.5. How has the political environment affected players?

    7.6. Are there any threats to leading players?

    8 Company Profiles

    8.1. Merck & Co., Inc.

    8.2. Amgen, Inc.

    8.3. Novartis AG

    8.4. Sanofi SA

    8.5. Takeda Pharmaceutical Company Limited

    9 Macroeconomic Indicators

    9.1. Country data

    10 Appendix

    10.1. Methodology

    10.2. Industry associations

    10.3. Related MarketLine research

    10.4. About MarketLine

List Of Tables
in Global Biotechnology

List of Tables

Table 1: Global biotechnology industry value: $ billion, 2014-18

Table 2: Global biotechnology industry category segmentation: $ billion, 2018

Table 3: Global biotechnology industry geography segmentation: $ billion, 2018

Table 4: Global biotechnology industry value forecast: $ billion, 2018-23

Table 5: Merck & Co., Inc.: key facts

Table 6: Merck & Co., Inc.: Annual Financial Ratios

Table 7: Merck & Co., Inc.: Key Employees

Table 8: Merck & Co., Inc.: Key Employees Continued

Table 9: Amgen, Inc.: key facts

Table 10: Amgen, Inc.: Annual Financial Ratios

Table 11: Amgen, Inc.: Key Employees

Table 12: Amgen, Inc.: Key Employees Continued

Table 13: Novartis AG: key facts

Table 14: Novartis AG: Annual Financial Ratios

Table 15: Novartis AG: Key Employees

Table 16: Novartis AG: Key Employees Continued

Table 17: Sanofi SA: key facts

Table 18: Sanofi SA: Annual Financial Ratios

Table 19: Sanofi SA: Key Employees

Table 20: Sanofi SA: Key Employees Continued

Table 21: Takeda Pharmaceutical Company Limited: key facts

Table 22: Takeda Pharmaceutical Company Limited: Annual Financial Ratios

Table 23: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)

Table 24: Takeda Pharmaceutical Company Limited: Key Employees

Table 25: Takeda Pharmaceutical Company Limited: Key Employees Continued

Table 26: Global exchange rate, 2014-18

List Of Figures, Charts and Diagrams
in Global Biotechnology

List of Figures

Figure 1: Global biotechnology industry value: $ billion, 2014-18

Figure 2: Global biotechnology industry category segmentation: % share, by value, 2018

Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2018

Figure 4: Global biotechnology industry value forecast: $ billion, 2018-23

Figure 5: Forces driving competition in the global biotechnology industry, 2018

Figure 6: Drivers of buyer power in the global biotechnology industry, 2018

Figure 7: Drivers of supplier power in the global biotechnology industry, 2018

Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2018

Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2018

Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2018

Additional Details

Publisher

Marketline

Publisher Information

Reference

260953 |

Number of Pages

53

Report Format

PDF

Marketline Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review provides you...
24 Nov 2015 by Global Data USD $125 More Info
Puma Biotechnology, Inc. (PBYI) - Financial and Strategic SWOT Analysis Review
SummaryPuma Biotechnology, Inc. (Puma) is a biopharmaceutical company that develops and markets ther...
08 Nov 2015 by Global Data USD $300 More Info
Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review
SummaryPrana Biotechnology Limited (Prana Biotech) is a pharmaceutical company that develops therape...
08 Nov 2015 by Global Data USD $300 More Info
Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic SWOT Analysis Review
SummaryGenovate Biotechnology Co., Ltd. (GBL) is a pharmaceutical company that offers formulations. ...
08 Nov 2015 by Global Data USD $300 More Info
Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review
SummaryTamir Biotechnology, Inc. (formerly known as Alfacell Corporation) is a biopharmaceutical com...
08 Nov 2015 by Global Data USD $300 More Info
Level Biotechnology Inc. (3118) - Financial and Strategic SWOT Analysis Review
SummaryLevel Biotechnology Inc. (LBI) is a biotechnology company that offers molecular biology produ...
08 Nov 2015 by Global Data USD $300 More Info
G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis Review
SummaryG&E Herbal Biotechnology Co., Ltd. (G&E Herbal) is a biopharmaceutical company that offers re...
08 Nov 2015 by Global Data USD $300 More Info
Anhui Anke Biotechnology (Group) Co., Ltd. (300009) - Financial and Strategic SWOT Analysis Review
SummaryAnhui Anke Biotechnology (Group) Co., Ltd. (AnkeBio) is a biotechnology company that develops...
08 Nov 2015 by Global Data USD $300 More Info
Golden Biotechnology Corp. (4132) - Financial and Strategic SWOT Analysis Review
SummaryGolden Biotechnology Corp. (Golden Biotech) is a biotechnology company that develops drugs. T...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Have expectations been reset for Puma Biotechnology's neratinib in HER2+ breast cancer?
Scope Investors appear to be resetting their expectations for Puma Biotechnology's experimental HER2...
01 May 2015 by FirstWord Pharma USD $695 More Info

This report is published by Marketline

Download Free Report Summary PDF

Global Biotechnology | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...